Your browser doesn't support javascript.
loading
Outcomes and risk factors of SARS-CoV-2 omicron variant in B-cell lymphoma patients following CD19 targeted CAR-T therapy.
Xiao, Xibin; Chen, Panpan; Zhong, Yadi; Luo, Xiu; Liu, Yao; Lu, Ying; Jin, Xueli; Qian, Wenbin; Han, Weidong; Liang, Aibin; Liu, Hui.
Afiliación
  • Xiao X; Department of Hematology, The Second Affiliated Hospital, College of Medicine, Zhejiang University, Hangzhou, China.
  • Chen P; Department of Hematology, The Second Affiliated Hospital, College of Medicine, Zhejiang University, Hangzhou, China.
  • Zhong Y; Department of Bio-Therapeutic, The First Medical Centre, Chinese People's Liberation Army General Hospital, Beijing, China.
  • Luo X; Department of Hematology, Tongji Hospital, Tongji University School of Medicine, Shanghai, China.
  • Liu Y; Department of Hematology Oncology, Chongqing University Cancer Hospital, Chongqing, China.
  • Lu Y; Department of Hematology, Yinzhou Hospital, Affiliated to College of Medicine, Ningbo University, Ningbo, China.
  • Jin X; Department of Hematology, The Second Affiliated Hospital, College of Medicine, Zhejiang University, Hangzhou, China.
  • Qian W; Department of Hematology, The Second Affiliated Hospital, College of Medicine, Zhejiang University, Hangzhou, China.
  • Han W; Department of Bio-Therapeutic, The First Medical Centre, Chinese People's Liberation Army General Hospital, Beijing, China.
  • Liang A; Department of Hematology, Tongji Hospital, Tongji University School of Medicine, Shanghai, China.
  • Liu H; Department of Hematology, The Second Affiliated Hospital, College of Medicine, Zhejiang University, Hangzhou, China.
Cancer Med ; 12(22): 20838-20846, 2023 11.
Article en En | MEDLINE | ID: mdl-37962082
Asunto(s)
Palabras clave
Texto completo
Añadir a Mi BVS
Imprimir
XML
PubMed Links
Buscar en Google

Texto completo: 1 Colección: 01-internacional Base de datos: MEDLINE Asunto principal: Linfoma de Células B / Receptores Quiméricos de Antígenos / COVID-19 Límite: Humans / Middle aged Idioma: En Revista: Cancer Med Año: 2023 Tipo del documento: Article País de afiliación: China Pais de publicación: Estados Unidos
Texto completo
Añadir a Mi BVS
Imprimir
XML
PubMed Links
Buscar en Google

Texto completo: 1 Colección: 01-internacional Base de datos: MEDLINE Asunto principal: Linfoma de Células B / Receptores Quiméricos de Antígenos / COVID-19 Límite: Humans / Middle aged Idioma: En Revista: Cancer Med Año: 2023 Tipo del documento: Article País de afiliación: China Pais de publicación: Estados Unidos